市場調查報告書

子宮頸癌症診斷檢驗的全球市場 - 檢驗的各類型、各年齡層、各地區:市場規模、佔有率、未來展望、機會分析

Cervical Cancer Diagnostic Tests Market, By Test Type, By Age Group, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

出版商 Coherent Market Insights 商品編碼 952818
出版日期 內容資訊 英文 110 Pages
商品交期: 2-3個工作天內
價格
子宮頸癌症診斷檢驗的全球市場 - 檢驗的各類型、各年齡層、各地區:市場規模、佔有率、未來展望、機會分析 Cervical Cancer Diagnostic Tests Market, By Test Type, By Age Group, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
出版日期: 2020年07月14日內容資訊: 英文 110 Pages
簡介

本報告提供全球子宮頸癌症診斷檢驗的市場相關分析,疾病、技術概要,及市場基本結構及促進、阻礙因素,整體市場規模預測 (以金額為準,過去3年、今後8年份),檢驗的各類型、各年齡層、各地區的詳細趨勢,主要企業的簡介、業績、策略計劃等調查。

目錄

第1章 分析目的、前提條件

第2章 市場概要

  • 分析概要
  • 摘要整理
    • COM (Coherent Opportunity Map:市場機會藍圖)

第3章 市場動態、規定、趨勢分析

  • 市場動態
    • 推動市場要素
    • 阻礙市場要素
    • 市場機會
  • 影響度分析
  • 近幾年主要的動向
  • 產品銷售
  • PEST分析
  • 技術進步
  • 法規方案
  • 企業合併、收購 (M&A)
  • 新型冠狀病毒感染疾病 (COVID-19)的影響

第4章 全球子宮頸癌症診斷檢驗市場:檢驗的各類型

  • 簡介
  • 子宮頸抹片(PAP)檢驗
  • 陰道鏡檢查
  • ECC (刮宮術)

第5章 全球子宮頸癌症診斷檢驗市場:各年齡層

  • 簡介
  • 20∼40歲
  • 40歲以上

第6章 全球子宮頸癌症診斷檢驗市場:各地區

  • 簡介
  • 北美
  • 南美
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第7章 競爭情形

  • 企業簡介
    • Guided Therapeutics
    • Abbott Laboratories
    • Beckman Coulter Inc.
    • Becton, Dickinson and Company

第8章 附錄

目錄

Cervical Cancer occurs in the cells of the cervix. Pap smear, colposcopy, and ECC procedure are performed for the diagnosis of cervical cancer. Increasing product approval, along with increasing prevalence of cervical cancer in developing economies is expected to assist the growth of the market during the forecast period. Furthermore, increasing awareness regarding cervical cancer in developing economies and increasing funding for R&D in diagnosis of cervical cancer is also anticipated to drive the growth of the market during the forecast period.

Key features of the study:

  • This report provides in-depth analysis of the Global Cervical Cancer Diagnostic Tests market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2020-2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the Global Cervical Cancer Diagnostic Tests market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Guided Therapeutics, Abbott Laboratories, Beckman Coulter Inc., and Becton, Dickinson and Company.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The Global Cervical Cancer Diagnostic Tests market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Cervical Cancer Diagnostic Tests market

Detailed Segmentation:

  • Global Cervical Cancer Diagnostic Tests Market, By Test Type:
    • Pap Smear Test Procedure
    • Colposcopy Procedure
    • ECC Procedures
  • Global Cervical Cancer Diagnostic Tests Market, By Age Group:
    • Age 20 - 40
    • Age above 40
  • Global Cervical Cancer Diagnostic Tests Market, By Region:
    • North America
      • By Test Type:
      • Pap Smear Test Procedure
      • Colposcopy Procedure
      • ECC Procedures
      • By Age Group
      • Age 20 - 40
      • Age above 40
      • By Country
      • U.S.
      • Canada
    • Latin America
      • By Test Type:
      • Pap Smear Test Procedure
      • Colposcopy Procedure
      • ECC Procedures
      • By Age Group
      • Age 20 - 40
      • Age above 40
      • By Country
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Test Type:
      • Pap Smear Test Procedure
      • Colposcopy Procedure
      • ECC Procedures
      • By Age Group
      • Age 20 - 40
      • Age above 40
      • By Country
      • U.K.
      • Germany
      • France
      • Spain
      • Italy
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Test Type:
      • Pap Smear Test Procedure
      • Colposcopy Procedure
      • ECC Procedures
      • By Age Group
      • Age 20 - 40
      • Age above 40
      • By Country
      • China
      • Japan
      • India
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Test Type:
      • Pap Smear Test Procedure
      • Colposcopy Procedure
      • ECC Procedures
      • By Age Group
      • Age 20 - 40
      • Age above 40
      • By Country
      • GCC Countries
      • Israel
      • Rest of Middle East
    • Africa
      • By Test Type:
      • Pap Smear Test Procedure
      • Colposcopy Procedure
      • ECC Procedures
      • By Age Group
      • Age 20 - 40
      • Age above 40
      • By Country
      • North Africa
      • Central Africa
      • South Africa
  • Company Profiles
    • Guided Therapeutics *
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Abbott Laboratories
    • Beckman Coulter Inc.
    • Becton, Dickinson and Company
  • "*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Test Type
    • Market Snippet, By Age Group
    • Market Snippet, By Country
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Key Highlights
  • Product launch
  • PEST Analysis
  • Technological Advancements
  • Regulatory Scenario
  • Mergers and Acquisitions
  • COVID19 Impact on Market

4. Global Cervical Cancer Diagnostic Tests Market, By Test Type, 2019 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Pap Smear Test Procedure
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Colposcopy Procedure
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • ECC Procedures
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

5. Global Cervical Cancer Diagnostic Tests Market, By Age Group, 2019 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Age 20 - 40
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Age above 40
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

6. Global Cervical Cancer Diagnostic Tests Market, By Region, 2019 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2026
  • North America
    • Market Size and Forecast, By Test Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Age Group, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Test Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Age Group, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Test Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Age Group, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Test Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Age Group, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Test Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Age Group, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Test Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Age Group, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • North Africa
    • Central Africa
    • South Africa

7. Competitive Landscape

  • Company Profiles
    • Guided Therapeutics
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Abbott Laboratories
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Beckman Coulter Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Becton, Dickinson and Company
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies

8. Section

  • References
  • Research Methodology
  • About us and Sales Contact